These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Medication Administration Delays in Non-ST Elevation Myocardial Infarction: Analysis of 1002 Patients Admitted to an Academic Medical Center. Denlinger LN; Keeley EC Crit Pathw Cardiol; 2018 Jun; 17(2):73-76. PubMed ID: 29768314 [TBL] [Abstract][Full Text] [Related]
24. Bleeding versus thrombosis: role of short DAPT in complex lesions. Calcagno S; Lucisano L; Mancone M; Cavallo E; Pennacchi M; Stio RE; Sardella G Minerva Cardioangiol; 2015 Dec; 63(6):533-46. PubMed ID: 26334115 [TBL] [Abstract][Full Text] [Related]
26. Impact of greater than 12-month dual antiplatelet therapy duration on mortality: Drug-specific or a class-effect? A meta-analysis. Costa F; Adamo M; Ariotti S; Navarese EP; Biondi-Zoccai G; Valgimigli M Int J Cardiol; 2015 Dec; 201():179-81. PubMed ID: 26298373 [No Abstract] [Full Text] [Related]
27. Optimal DAPT duration: each in their own time. Hillegass WB; Brott BC Catheter Cardiovasc Interv; 2015 Jan; 85(1):41-2. PubMed ID: 25521927 [No Abstract] [Full Text] [Related]
28. Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Review of the Evidence. Montalescot G; Brieger D; Dalby AJ; Park SJ; Mehran R J Am Coll Cardiol; 2015 Aug; 66(7):832-847. PubMed ID: 26271067 [TBL] [Abstract][Full Text] [Related]
30. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF; Circulation; 2010 Dec; 122(24):2619-33. PubMed ID: 21060077 [No Abstract] [Full Text] [Related]
31. Is the Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents the Longer the Better? Huang QY; Bista M; Yang RQ Med Princ Pract; 2015; 24(4):398. PubMed ID: 25924625 [No Abstract] [Full Text] [Related]
32. Ticagrelor: the first novel reversible P2Y(12) inhibitor. Htun WW; Steinhubl SR Expert Opin Pharmacother; 2013 Feb; 14(2):237-45. PubMed ID: 23268703 [TBL] [Abstract][Full Text] [Related]
33. Determination of the prevalence of aspirin and clopidogrel resistances in patients with coronary artery disease by using various platelet-function tests. Woo KS; Kim BR; Kim JE; Goh RY; Yu LH; Kim MH; Han JY Korean J Lab Med; 2010 Oct; 30(5):460-8. PubMed ID: 20890076 [TBL] [Abstract][Full Text] [Related]
34. Effects of P2Y12 receptor inhibition with or without aspirin on hemostatic system activation: a randomized trial in healthy subjects. Traby L; Kollars M; Kaider A; Eichinger S; Wolzt M; Kyrle PA J Thromb Haemost; 2016 Feb; 14(2):273-81. PubMed ID: 26663880 [TBL] [Abstract][Full Text] [Related]
35. Should P2Y12 inhibitors be given for 12 months in acute coronary syndrome? Christodoulidis G; Baber U; Mehran R Curr Opin Cardiol; 2014 Jul; 29(4):301-6. PubMed ID: 24842783 [TBL] [Abstract][Full Text] [Related]
36. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Kushner FG; Hand M; Smith SC; King SB; Anderson JL; Antman EM; Bailey SR; Bates ER; Blankenship JC; Casey DE; Green LA; Hochman JS; Jacobs AK; Krumholz HM; Morrison DA; Ornato JP; Pearle DL; Peterson ED; Sloan MA; Whitlow PL; Williams DO; Circulation; 2009 Dec; 120(22):2271-306. PubMed ID: 19923169 [No Abstract] [Full Text] [Related]
37. A systematic review of guidelines for dual antiplatelet therapy in coronary artery bypass graft. Zhang ZZ; Zhang SZ; Zhou HM; Fan YQ; Liu MH; Zhong XB; Yang DY; Guo Y; Zhuang XD; Liao XX Eur J Clin Invest; 2021 Jan; 51(1):e13405. PubMed ID: 32926588 [TBL] [Abstract][Full Text] [Related]
39. Predictors of high on-aspirin platelet reactivity in high-risk vascular patients treated with single or dual antiplatelet therapy. Amsallem M; Manzo-Silberman S; Dillinger JG; Sideris G; Voicu S; Bal dit Sollier C; Drouet L; Henry P Am J Cardiol; 2015 May; 115(9):1305-10. PubMed ID: 25759104 [TBL] [Abstract][Full Text] [Related]
40. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]